Drug Profile
Research programme: site-1 protease inhibitors - Pfizer
Alternative Names: PF 429242; Research programme: sterol regulatory element binding protein site-1 protease inhibitorsLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pfizer
- Class Benzamides; Pyrrolidines
- Mechanism of Action Cholesterol synthesis inhibitors; Transcription factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lipid metabolism disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Lipid-metabolism-disorders in USA